Joseph B. Armes - Sep 15, 2025 Form 4 Insider Report for CSW INDUSTRIALS, INC. (CSW)

Signature
/s/Luke E. Alverson, Attorney in Fact
Stock symbol
CSW
Transactions as of
Sep 15, 2025
Transactions value $
-$250,000
Form type
4
Date filed
9/16/2025, 04:51 PM
Previous filing
Aug 18, 2025
Next filing
Oct 3, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Armes Joseph B Chairman, President & CEO, Director 5420 LYNDON B JOHNSON FWY, STE. 500, DALLAS /s/Luke E. Alverson, Attorney in Fact 2025-09-16 0001413614

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSW Common Stock Sale -$250K -1K -1.6% $250.00 61.5K Sep 15, 2025 Direct F1
holding CSW Common Stock 3.22K Sep 15, 2025 by ESOP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CSW Performance Rights 8K Sep 15, 2025 Common Stock 8K Direct F2
holding CSW Performance Rights 8.24K Sep 15, 2025 Common Stock 8.24K Direct F3
holding CSW Performance Rights 12.4K Sep 15, 2025 Common Stock 12.4K Direct F4
holding CSW Performance Rights 18.4K Sep 15, 2025 Common Stock 18.4K Direct F5
holding CSW Restricted Stock Units 19.7K Sep 15, 2025 Common Stock 19.7K Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.
F2 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025 and ending on March 31, 2028 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F3 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F4 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F5 Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles beginning April 1, 2021 ending on each of March 31, 2026 and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
F6 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.